Efficacy ans safety of subcutaneous Efalizumab in the treatment of patients with cutaneous lupus erythematosus: A mono-centre, open-label, prospective pilot study - EFALUPUS Efficacy ans safety of subcutaneous Efalizumabin the treatment of patients with cutaneous lupus eryt ...
Efficacy ans safety of subcutaneous Efalizumab in the treatment of patients with cutaneous lupus erythematosus: A mono-centre, open-label, prospective pilot study - EFALUPUS Efficacy ans safety of subcutaneous Efalizumabin the treatment of patients with cutaneous lupus eryt ...
Cutaneous lupus erythematosus (discoid LE or subacute cutaneous LE) or systemic lupus erythematosus with cutaneous DLE or SCLE lesions without major organ involvment. MedDRA version: 9.1;Level: LLT;Classification code 10013071;Term: Discoid lupus erythematosis MedDRA version: 9.1;Classification code 10057903;Term: Subacute cutaneous lupus erythematosus MedDRA version: 9.1;Classification code 10056509;Term: Cutaneous lupus erythematosus Cutaneous lupus erythematosus (discoid LE or subacute cutaneous LE) or systemic lupus erythematosus ...